Group items tagged

The Professional Records Standards Body (PRSB), which develops information standards for health and social care records, has appointed Professor Reecha Sofat as the new Chair. She will assume the role at the end of October 2024, succeeding Professor Maureen Baker CBE, who will step down after seven years as Chair of the PRSB. A Clinical Pharmacologist, Professor Sofat has held many leadership roles across the NHS, academia and scientific societies. Professor Sofat is Breckenridge Chair of Clinical Pharmacology at the University of Liverpool. She practices general internal medicine and is also an Associate Director at the British Heart Foundation (BHF) Data Science Centre (DSC) which is led by Health Data Research UK (HDRUK). With a passion for data science and extensive clinical and research insights, Professor Sofat is focused on embedding research into routine health and social care. She said: "I am passionate about using the rich health data that is already collected across NHS and social care to better understand the causes and consequences of disease and improve health outcomes.

In a powerful display of unity, thousands of pharmacies across the UK participated in a nationwide protest today, organised by the National Pharmacy Association (NPA), as part of its #saveourpharmacies campaign. The NPA's day of action was aimed at drawing attention to the severe crisis in pharmacy funding that has forced 1,400 pharmacies to close over the past decade and left thousands more struggling. Participating pharmacies showed their protest through various actions like dimming lights, blacking out their windows, wearing black for the day, or discussing pharmacy funding with customers. Many pharmacies also seized the opportunity to interact with parliamentary candidate, urging them to address the funding crisis.

In a surprising move that has divided the pharmacy profession, the General Pharmaceutical Council (GPhC) has sanctioned hundreds of pharmacies to allow patients to self-select certain Pharmacy (P) medicines, a decision met with strong opposition from the Royal Pharmaceutical Society (RPS) as well as from the Pharmacy Defense Association (PDA). In a statement, RPS shared that at a board meeting held on 19th June, they expressed "disappointment" over what they described as a lack of prior consultation and comprehensive communication from the GPhC regarding the implications of this policy shift. They argue that allowing patients to self-select certain P medicines could potentially jeopardize established professional guidelines and compromise the role of pharmacists in ensuring safe medication use. "Enabled by the General Pharmaceutical Council, we understand that hundreds of pharmacies, from large multiples to small independents, have been approved by the regulator to enable patients to self-select certain P medicines," the statement said.

"I dread the day, the accountant turns to me and says 'this isn't working' - as an owner, we shelter our patients and teams from the financial pressures we feel on a daily basis," shares S.G Barai Pharmacy owner, Reena Barai. Today, S.G Barai Pharmacy in Sutton, Surrey joined pharmacies nationwide in the #SaveOurPharmacies day of action, organised by the National Pharmacy Association (NPA) to spotlight the critical funding crisis facing community pharmacies across the UK. Recent figures reveal that over the past decade, more than 1,400 pharmacies have closed in England, Wales, and Northern Ireland, with additional closures looming in Scotland due to financial pressures. The NPA reports that three-quarters of pharmacies are operating at a loss, exacerbated by real-terms cuts to funding. "We turned our lights off and wore black today to symbolize the precarious situation pharmacies like ours are facing," said Reena Barai who owns the pharmacy.

The International Pharmaceutical Federation (FIP) has announced its support for the Pharmacists' Defence Association (PDA)'s Safer Pharmacies Charter, which aims to improve safety and care for patients, through better working conditions in UK pharmacy practice. The Charter establishes basic standards to ensure safe practices across all pharmacy settings. It outlines seven commitments that, according to the PDA, "must be standard practice whenever and wherever pharmacy work is carried out." Dr Catherine Duggan, FIP CEO, said: "We are pleased to support the PDA's Safer Pharmacies Charter which defines basic standards to ensure safe practice wherever pharmacists work. "The overall objectives of the Charter align with FIP's development goals and overall mission." FIP, the global body representing pharmacy and pharmaceutical sciences, plans to distribute the Charter among its members and share it with its Community Pharmacy Section for information purposes.

Healthcare professionals in the UK are being advised to avoid prescribing the migraine and antiseizure medication topiramate, commonly known by the brand name Topamax, to women and girls unless they fulfil the requirements of a Pregnancy Prevention Programme. This guidance follows new safety measures introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) following a major safety review, which highlighted a potential increased risk of neurodevelopmental disabilities in children exposed to topiramate during pregnancy. The Commission on Human Medicines (CHM) evaluated studies that examined the risks associated with using topiramate during pregnancy. These studies indicated that children born to mothers who took topiramate during pregnancy had an approximately 2 to 3 times higher risk of intellectual disability, autism spectrum disorders, and attention deficit hyperactivity disorder. Based on CHM's recommendations, the MHRA now advises that topiramate should not be prescribed for treating epilepsy during pregnancy unless there is no suitable alternative.

Despite being more connected than ever, the majority of Europeans are experiencing feelings of loneliness. The STADA Health Report 2024, released on Monday, revealed that over half (52 per cent) of Europeans "always, often or occasionally" feel lonely. Although the younger generation reports the highest levels of overall happiness, they are the ones most affected by this current loneliness epidemic. Nearly two-thirds (63 per cent) of Europeans aged 18 to 35 reported feeling lonely, compared to 41 percent of those aged 55 and older - according to the report, based on a survey of over 46,000 respondents aged 18 to 99 across 32 countries. Extensive screen time is contributing to increased loneliness among younger people. Europeans under the age of 34 are much more likely to spend long hours on their devices (41 per cent) than those aged 35-54 (22 per cent) and those over 55 (13 per cent). The survey found that people who spend a "long" or "fair" amount of time on social media were significantly more prone to feelings of loneliness compared to those who restrict their screen time. Moreover, extensive screen time was also associated with more intense feelings of loneliness.

Sustainability also brings financial benefits to businesses. This has been proven by Prabjaudt Singh Channa, Director of Priory Pharmacy. Prabjaudt is a proud winner of the Sustainable Pharmacy of the Year 2023, awarded by Pharmacy Business in association with Teva UK. Prabjaudt thanked the award organisers for acknowledging the importance of sustainability within the sector and for recognising his modest endeavours to reduce environmental impact and safeguard future generations. "I just felt really happy and proud of this recognition because originally when I set myself down on this path, I didn't really think anyone would be that bothered about the small changes that we were trying to make and the impact," says Prabjaudt. In addition to his family's background in the field, his passion for chemistry also drove him to pursue a career in pharmacy. He finds being a pharmacy contractor enjoyable because it allows him to be flexible, pursue various interests and shape his professional path.

Ensuring comprehensive healthcare services for the community necessitates collaboration between pharmacies and GP surgeries. However, several pharmacists have voiced concerns about a lack of cooperation from their local GPs in implementing the Pharmacy First (PF) service. In a survey conducted by the National Pharmacy Association (NPA) covering 470 pharmacies across England, three-quarters of pharmacists (77 per cent) indicated that local GP practices are not appropriately referring patients to the new service. The survey highlighted instances of patients either not being referred or being referred but found ineligible for support through Pharmacy First. Additionally, one in five NPA members (19 per cent) felt that their local GP practices were not engaging with the initiative at all. Commenting on the issue, NPA chair Nick Kaye said: "Feedback from across our network suggests that the rollout of Pharmacy First varies considerably from area to area.

The Government has been forced to intervene formally 50 times in the past two years to authorise the use of alternative drugs because of serious medicine shortages hitting patients, new analysis by the National Pharmacy Association (NPA) has found today. 78 per cent of all Serious Shortage Protocols, produced by the Department of Health and Social Care (DHSC) due to medicine shortages, were issued in 2022/24 - more than three times the rate in the previous two years. The NPA, which represents independent community pharmacies in the UK, is warning that shortages are leading to pharmacists having to increasingly turn patients needing vital medication away. Analysis by the NPA of the NHS's Serious Shortage Protocols (SSPs) issued to pharmacies and other providers over the last five years has found that: The number of SSPs issued in the last two years is 3.5 times higher than in the previous two years.

Since its launch on January 31st, the Pharmacy First service by the Company Chemists Association (CCA) has achieved a significant milestone, completing over 200,000 consultations to date. This milestone underscores the service's vital role in providing same-day NHS care through community pharmacies across England. Recent analysis by the CCA has revealed a pressing need to bolster GP referrals, with disparities observed between different Integrated Care System (ICS) areas, resulting in what's described as a 'postcode lottery' for patients. CCA Chief Executive, Malcolm Harrison, emphasised the importance of sustained funding for Pharmacy First beyond 2025, ensuring its availability for patients, community pharmacies, and the wider NHS.

A recent analysis conducted by the Company Chemists' Association (CCA) has revealed stark disparities in patient engagement with the Pharmacy First service across the country, likening the pattern to a 'patchwork quilt'. It indicated that patients in the highest-performing Integrated Care System (ICS) received seven times more Pharmacy First consultations than those in the lowest-performing regions. As of April 21, more than 3,000 CCA member pharmacies had delivered 126,484 Pharmacy First consultations since the programme's launch. However, the analysis found significant regional variations, with nearly 13,000 consultations completed in the North East and North Cumbria ICS, while only 948 were completed in Gloucestershire ICS. The CCA calculated that if every ICS had as many consultations as the highest-performing ICS, there would have been an additional 600,000 Pharmacy First consultations nationwide.

Holland & Barrett, the UK's leading wellness retailer, has become the latest retailer regulatory member of PAGB, the consumer healthcare association. PAGB represents the manufacturers of branded over-the-counter (OTC) medicines, self care medical devices and food supplements in the UK. Holland & Barrett's decision to PAGB follows its recent introduction of a selected range of OTC and healthcare products in its stores across the UK. These include painkillers, cough and cold medicines, children's health essentials, hay fever relief, as well as skin and gastrointestinal products. With this expansion, the retailer aims to not only help customers to stay well, but also provide relief when needed.

The Company Chemists' Association (CCA) has responded positively to the Labour Party's manifesto, which outlines plans to bolster community pharmacy services and shift the NHS towards a more localized, prevention-focused model. Key proposals include the creation of a Community Pharmacist Prescribing Service and the enhancement of care delivery in local communities. Malcolm Harrison, Chief Executive of the CCA, expressed strong support for these initiatives and said: "We welcome the Labour Party Manifesto's clear focus on moving to a 'Neighbourhood Health Service', prevention, and the return of the 'family doctor'." "Harnessing community pharmacy is crucial to delivering each of these," Harrison added.

The National Pharmacy Association (NPA) has called for immediate intervention by Health Secretary Neil Gray to compensate pharmacies left in financial chaos due to flaws in Scotland's new pharmacy payment system. Introduced last year, the system was designed to streamline payments to pharmacies, dispensing doctors, and medical appliance suppliers. However, the NPA, which represents independent pharmacies across the UK, reported that many pharmacies were facing repeated shortfalls in expected funding under the system. Some pharmacies have encountered discrepancies of tens of thousands pounds due to errors in the Data Capture Validation & Pricing process introduced by NHS National Services Scotland. In other cases, NHS Boards have clawed back money from pharmacies at short notice, following processing errors that had initially resulted in an overpayment.

The Association of the British Pharmaceutical Industry (ABPI) has laid out a series of urgent actions it wants the newly elected Labour government to implement within its first 100 days in office. Among the top priorities, the ABPI has emphasised the urgent need to appoint a new Chair and Chief Executive for the Medicines and Healthcare products Regulatory Agency (MHRA). Additionally, the ABPI has urged the new government to launch the Life Sciences Manufacturing Capital Grants Facility without delay. Other measures the ABPI wants Labour to prioritise include: Rapidly passing outstanding UK clinical trials legislation to enhance the UK's attractiveness for inward investment, including into research within the NHS. Increasing commercial flexibility in the NHS England Commercial Framework for New Medicines to remove barriers for companies to launch new medicines and indications so that NHS patients can access the latest innovative medicines.

"The UK remains genuinely world-leading for life sciences in numerous areas - yet we continue to underperform on our potential," said Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI). His statement is based on recent government data indicating that the UK is not fully capitalizing on its strong historical and institutional advantages in life sciences across a range of economic, health, and research indicators. The latest 'Life sciences competitiveness indicators 2024' report from the government's Office for Life Sciences revealed that while the pharmaceutical industry leads in R&D spending with £9 billion in 2022, representing a fifth of total business investment, the country saw a notable decline in foreign direct investment (FDI), industry clinical trials, and exports. In 2023, FDI dropped by 21 per cent to £0.8 billion, following a trend that saw a 52 per cent decrease over the previous two years, including a £0.9 billion fall in FDI the year prior.

In significant development, the Pharmacists' Defence Association (PDA) has advised its Boots members to challenge the "trustees' decision to end the ability to take an unreduced pension from age 60 by submitting complaints through the scheme's two-stage internal disputes procedure". The issue centers around the alterations made to pension scheme rules without the adequate disclosure to scheme members or their representatives. The PDA has drafted template letters to assist scheme members in response to undisclosed changes during a buyout process, sparking legal challenges and demands for transparency from Boots and scheme trustees. Paul Moloney, National Officer of the PDA Union leading the campaign, expressed concern over the sudden withdrawal of the right to an unreduced pension from age 60. "We have always maintained that members had a right under the rules to draw an unreduced pension from age 60," Moloney stated.

The Pharmacists' Defence Association (PDA) has emerged as a key player in international humanitarian efforts, delivering millions of pounds worth of medical aid to disaster-hit regions. This marks a significant evolution for the PDA, which has embraced a leadership role in global relief initiatives. The PDA, a member of the Employed Pharmacists of Europe (EPhEU), responded to an urgent appeal from its Ukrainian members following the extensive damage to Ukraine's healthcare infrastructure during the military invasion. As the elected Secretary General of EPhEU, PDA Chairman Mark Koziol orchestrated a campaign encouraging public donations through 'Medicines to Ukraine' posters displayed in pharmacies across Europe. The campaign successfully raised over £4.5 million, which was used to procure and deliver essential medicines directly to Ukrainian Ministry of Health pharmacists.

The Proprietary Association of Great Britain (PAGB) has called on the new Labour government to prioritise six key actions within its first 100 days to harness the benefits of self-care for the public, the NHS, and the wider economy. Aimed to ease the burden on the NHS, the PAGB hopes that the suggest six key actions would help during the incoming winter illness season. According to PAGB, the NHS deals with approximately 25 million GP appointments and 5 million A&E visits each year for self-treatable conditions. By empowering individuals to manage their own health more effectively, the NHS could potentially save up to £1.7 billion annually. In her letter to Wes Streeting, Secretary of State for Health and Social Care, Michelle Riddalls, CEO of PAGB, urged the government to act promptly.